Related Experiment Video
Updated: Oct 5, 2025

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
Published on: October 13, 2023
Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy
Manisha Korb1, Allison Peck2, Lindsay N Alfano3
1Department of Neurology, University of California - Irvine School of Medicine, Orange, CA, USA. mkak@uci.edu.
Abstract:
Valosin-containing protein (VCP) associated multisystem proteinopathy (MSP) is a rare inherited disorder that may result in multisystem involvement of varying phenotypes including inclusion body myopathy, Paget's disease of bone (PDB), frontotemporal dementia (FTD), parkinsonism, and amyotrophic lateral sclerosis (ALS), among others. An international multidisciplinary consortium of 40+ experts in neuromuscular disease, dementia, movement disorders, psychology, cardiology, pulmonology, physical therapy, occupational therapy, speech and language pathology, nutrition, genetics, integrative medicine, and endocrinology were convened by the patient advocacy organization, Cure VCP Disease, in December 2020 to develop a standard of care for this heterogeneous and under-diagnosed disease. To achieve this goal, working groups collaborated to generate expert consensus recommendations in 10 key areas: genetic diagnosis, myopathy, FTD, PDB, ALS, Charcot Marie Tooth disease (CMT), parkinsonism, cardiomyopathy, pulmonology, supportive therapies, nutrition and supplements, and mental health. In April 2021, facilitated discussion of each working group's conclusions with consensus building techniques enabled final agreement on the proposed standard of care for VCP patients. Timely referral to a specialty neuromuscular center is recommended to aid in efficient diagnosis of VCP MSP via single-gene testing in the case of a known familial VCP variant, or multi-gene panel sequencing in undifferentiated cases. Additionally, regular and ongoing multidisciplinary team follow up is essential for proactive screening and management of secondary complications. The goal of our consortium is to raise awareness of VCP MSP, expedite the time to accurate diagnosis, define gaps and inequities in patient care, initiate appropriate pharmacotherapies and supportive therapies for optimal management, and elevate the recommended best practices guidelines for multidisciplinary care internationally.
Insights
Valosin-containing protein (VCP) associated multisystem proteinopathy (MSP) is a rare disorder affecting multiple systems. This study outlines expert consensus recommendations for its diagnosis and multidisciplinary care.
Area of Science:
- Neurology
- Genetics
- Rare Diseases
Background:
- Valosin-containing protein (VCP) associated multisystem proteinopathy (MSP) is a rare, inherited disorder with diverse phenotypes including myopathy, Paget's disease of bone (PDB), frontotemporal dementia (FTD), parkinsonism, and amyotrophic lateral sclerosis (ALS).
- The heterogeneity and under-diagnosis of VCP MSP necessitate standardized care protocols.
Purpose of the Study:
- To develop a standard of care for VCP MSP through an international multidisciplinary expert consortium.
- To address the diagnostic and management challenges of this rare multisystem disorder.
Main Methods:
- Convened a consortium of over 40 experts from various medical disciplines.
- Established working groups to generate consensus recommendations across 10 key areas of VCP MSP care.
- Utilized consensus-building techniques for final agreement on the standard of care.
Main Results:
- Developed expert consensus recommendations for the diagnosis and management of VCP MSP.
- Recommended timely referral to specialty neuromuscular centers for diagnosis via genetic testing.
- Emphasized the importance of regular, multidisciplinary team follow-up for proactive screening and management of complications.
Conclusions:
- The established standard of care aims to raise awareness, expedite diagnosis, and improve patient outcomes for VCP MSP.
- International collaboration and multidisciplinary care are crucial for optimal management of this complex disease.
- The guidelines provide a framework for best practices in the international management of VCP MSP.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Standards of Care I
Standards of Care II
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Myocarditis III: Medical Management

